Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
SJR
- PublisherELSEVIER SCIENCE INC
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1999
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 52% |
4-6 | 37% |
7-9 | 8% |
>9 | 3% |
Topics Covered
Recently Published Papers
FAQs
Since when has NEOPLASIA been publishing? 
The NEOPLASIA has been publishing since 1999 till date.
How frequently is the NEOPLASIA published? 
NEOPLASIA is published Monthly.
Who is the publisher of NEOPLASIA? 
The publisher of NEOPLASIA is ELSEVIER SCIENCE INC.
How can I view the journal metrics of NEOPLASIA on editage? 
For the NEOPLASIA metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of NEOPLASIA? 
The eISSN number is 1476-5586 and pISSN number is 1476-5586 for NEOPLASIA.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding Cancer, P53 pathway, Bone marrow, Lung cancer, Head and neck, Glioblastoma, DNA damage, Breast cancer, Tumor microenvironment, Drug delivery, Epidermal growth factor receptor, Extracellular vesicles, Cisplatin, Mathematical model, Neuroblastoma, Gene expression, Prostate cancer, Bystander effect, Overall survival, Hepatocellular carcinoma.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.